Early Stage Drug Development Company

We’re a high value-added company that applies photoisomerization conversion technology

Sales

Unit:1,000 KRW
Y2019 Y2020 Y2021
583,912 544,000 413,942

Gross profit

Unit:1,000 KRW
Y2019 Y2020 Y2021
496,690 412,861 413,942

Profit

Unit:1,000 KRW
Y2019 Y2020 Y2021
156,826 55,034 67,819

Net Income

Unit:1,000 KRW
Y2019 Y2020 Y2021
146,816 20,943 21,770